Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
5589 ARTÍCULOS , VIENDO DEL 1171 AL 1185
Present and future of subthalamotomy in the management of Parkinson´s disease: a systematic review
Máñez-Miró JU, Rodríguez-Rojas R, Del Álamo M, Martínez-Fernández R, Obeso JA.
Expert Rev Neurother. 2021 May;21(5):533-545. doi: 10.1080/14737175.2021.1911649. Epub 2021 May 6.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021 Apr.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021 Apr.
Kulenkampff K, Wolf Perez AM, Sormanni P, Habchi J, Vendruscolo M.
Nat Rev Chem. 2021 Apr;5(4):277-294. doi: 10.1038/s41570-021-00254-9. Epub 2021 Feb 15.
Akbar U, McQueen RB, Bemski J, Carter J, Goy ER, Kutner J, Johnson MJ, Miyasaki JM, Kluger B.
J Neurol Neurosurg Psychiatry. 2021 Mar 31;92(6):629-36. doi: 10.1136/jnnp-2020-323939. Online ahead of print.
Kim R, Park S, Yoo D, Jun JS, Jeon B.
Neurology. 2021 May 11;96(19):e2429-e2437. doi: 10.1212/WNL.0000000000011852. Epub 2021 Mar 31.
Physical Activity May Reduce Apolipoprotein E4-Associated Cognitive Decline in Parkinson Disease
Raber J, Darweesh SKL, Savica R.
Neurology. 2021 May 11;96(19):877-878. doi: 10.1212/WNL.0000000000011851. Epub 2021 Mar 31.
Impulse Control Disorders in Parkinson's Disease: From Bench to Bedside
Augustine A, Winstanley CA, Krishnan V.
Front Neurosci. 2021 Mar 12;15:654238. doi: 10.3389/fnins.2021.654238. eCollection 2021.
Membrane Interactions and Toxicity by Misfolded Protein Oligomers
Gonzalez-Garcia M, Fusco G, De Simone A.
Front Cell Dev Biol. 2021 Mar 11;9:642623. doi: 10.3389/fcell.2021.642623. eCollection 2021.
Biofeedback-Based Connected Mental Health Interventions for Anxiety: Systematic Literature Review
Alneyadi M, Drissi N, Almeqbaali M, Ouhbi S.
JMIR Mhealth Uhealth. 2021 Apr 22;9(4):e26038. doi: 10.2196/26038.
Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial
Rascol O, Cochen de Cock V, Pavy-Le Traon A, Foubert-Samier A, Thalamas C, Sommet A, Rousseau V, Perez-Lloret S, Fabbri M, Azulay JP, Corvol JC, Couratier P, Damier P, Defebvre L, Durif F, Geny C, Houeto JL, Remy P, Tranchant C, Verin M, Tison F, Meissner WG; MSA-FLUO Study Group.
Mov Disord. 2021 Jul;36(7):1704-1711. doi: 10.1002/mds.28569. Epub 2021 Apr 1.
Diagnosis and cure of supraventricular tachycardia
Morady F.
Heart Rhythm. 2021 Apr;18(4):651-652. doi: 10.1016/j.hrthm.2020.11.010.
Unraveling the Link Between Mitochondrial Dynamics and Neuroinflammation
de Oliveira LG, Angelo YS, Iglesias AH, Peron JPS.
Front Immunol. 2021 Mar 16;12:624919. doi: 10.3389/fimmu.2021.624919. eCollection 2021.
Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta-Analysis
Nijhuis FAP, Esselink R, de Bie RMA, Groenewoud H, Bloem BR, Post B, Meinders MJ.
Mov Disord. 2021 Jun;36(6):1293-1307. doi: 10.1002/mds.28599. Epub 2021 Apr 2.
Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies
Ma L, Gholam Azad M, Dharmasivam M, Richardson V, Quinn RJ, Feng Y, Pountney DL, Tonissen KF, Mellick GD, Yanatori I, Richardson DR.
Redox Biol. 2021 May;41:101896. doi: 10.1016/j.redox.2021.101896. Epub 2021 Feb 14.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.